Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Election committee for Vitrolife AB (publ)

The following people have been appointed as members of Vitrolife’s election committee for the Annual General Meeting in 2021: Niels Jacobsen, appointed by William Demant Invest A/SPatrik Tigerschiöld, appointed by Bure Equity ABWendy Wang, appointed by Morgan Stanley Investment Management Inc.Jón Sigurdsson, Chairman of the BoardThe appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee which were determined at the Annual General Meeting of Vitrolife on June 15, 2020. The Annual General Meeting

Heimstaden AB: Interim report January-September 2020

Highlights · Rental income for the period was up 45 percent compared to 2019, primarily driven by acquisitions. · Like-for-like rental income growth was 4 percent. · The net operating income margin increased to 59 percent (57), mainly due to lower repair and maintenance costs. · Continued strong performance and resilient markets have resulted in limitedimpact from Covid-19. · Acquisitions amounted to SEK 20,217 million and change in fair value ofinvestment- and development properties amounted to SEK 6,045 million (4,900). · As of September 30, 2020, the fair value of

Heimstaden Bostad: Interim report January-September 2020

Highlights · Rental income for the period was up 66 percent compared to 2019, primarily driven by acquisitions. · Like-for-like rental income growth was 4 percent. · The net operating income margin increased to 58 percent (57), mainly due to lower repair and maintenance costs. · Continued strong performance and resilient markets have resulted in limited impact from Covid-19. · Acquisitions amounted to SEK 20,217 million and change in fair value ofinvestment- and development properties amounted to SEK 6,044 million (3,324). · As of September 30, 2020, the fair value of

Detection Technology’s financial calendar for 2021

Detection Technology Plc company announcement 28 October 2020 at 10:00 (EET) Detection Technology’s financial calendar for 2021 Detection Technology Plc will disclose the following financial releases in 2021: · Financial statements review 2020: 2 February 2021 · Business review January-March 2021: 27 April 2021 · Half-yearly report January-June 2021: 3 August 2021 · Business review January-September 2021: 27 October 2021 The financial statements and annual review for 2020 will be published latest on 4 March 2021 on the company’s website. The Annual General Meeting is

airteam wins ventilation contract in connection with the construction of the Multibrugerhuset with associated towers outside Copenhagen

airteam has won a major ventilation contract for the construction of the so called Multibrugerhuset with associated towers at Posthusgrunden (a former post office building) in Værløse just outside of Copenhagen.The project to construct the Multibrugerhuset building and the towers includes the construction of office buildings, residential units, hotel apartments, retail units and a health centre in the town of Værløse on the outskirts of Copenhagen. The total project encompasses an area of approximately 92,000 square metres. airteam’s contract includes the delivery and installation of many

BioStock: Chordate Medical can resume migraine study in Finland

Chordate Medical’s treatment, Kinetic Oscillation Stimulation, is currently being evaluated in a clinical study in patients with chronic migraine in Germany and Finland. Due to Covid-19, however, the Finnish part of the migraine study has been paused since March. Last week, Chordate Medical announced that the patient recruitment in Finnish study clinics will be resumed. According to the company, this means that the last patient will be treated in the study during the first quarter of 2021.Read the full article at biostock.se: https://www.biostock.se/en/chordate-medical-can-resume-

SOTKAMO SILVER AB: RELEASES OF FINANCIAL RESULTS 2021

Press release: Stockholm, October 28, 2020 08:45 CET In 2021 Sotkamo Silver AB will publish a financial results statement, half-year report and interim reports as follows: · Financial results for 2020, February 17, 2021 · Annual report in March 2021 · Interim report for January-March, April 22, 2021 · Half-year report January-June, July 15, 2021 · Interim report for January-September, October 15, 2021 · Financial results for 2021, February 17, 2022 Full Financial results report is available in Swedish and English on company’s internet pages, www.silver.fi.

Storytel goes live in Belgium today

Today Storytel, one of the world’s largest streaming services for audiobooks and e-books, goes live in Belgium. The launch strengthens Storytel’s presence in the Benelux region and will include extensive marketing initiatives in Belgium, including TV advertisements as well as social media and online campaigns.On 24 September, Storytel announced its expansion to Belgium launching a local service operated by Storytel Netherlands. Belgian subscribers will from day one have access to more than 250 000 audiobooks and e-books in a catalogue featuring both international bestsellers and strong

BioStock: Bayer acquires gene therapy company AskBio in billion-dollar deal

The pace of development in gene therapies has accelerated; new treatments are on the way and the interest from investors and the life science sector has certainly not diminished. The area has now received further attention with Bayer’s acquisition of Asklepios BioPharmaceuticals, which was announced on Monday. The purchase price amounted to two billion USD and another two billion when agreed milestones are reached.Read the full article on the gene therapy deal at biostock.se: https://www.biostock.se/en/bayer-acquires-gene-therapy-company-askbio-in-billion-dollar-deal/ This is a

Leadership. Nordic strength areas. Asian business logic. Programme start for Gothenburg Executive MBA 2020–2022

Early October, the Executive MBA programme 2020–2022 started at the School of Business, Economics and Law at the University of Gothenburg. Over 21 months, the 16 participating leaders will develop a wide range of skills and capabilities to prepare them for more extensive business responsibilities and developed leadership capabilities in a rapidly changing, global world. The part-time education is delivered in English and has a special focus on the Nordic countries and Asia. The lecturers come from the School of Business, Economics and Law and its partner universities around the world.

Nomination committee appointed ahead of 2021 Annual General Meeting of Pricer AB

Pricer AB (publ) has appointed the nomination committee ahead of the 2021 Annual General Meeting.In accordance with the decision at the Annual General Meeting on May 6, 2020 Pricer’s Chairman of the Board Knut Faremo has contacted the company’s three largest shareholders to form a Nomination Committee. Shareholders shall also include such a group of two or more shareholders who have notified the Chairman of the Board that they wish to participate jointly in the Nomination Committee's work. The shareholders and representatives comprising the Nomination Committee are:– Jari Ekblad,

Immunovia to Host Webinar Introducing New CEO, Patrik Dahlen

LUND, SWEDEN – Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced that the company will host a webinar to introduce incoming CEO, Patrik Dahlen on Tuesday, November 3[rd], 2020 at 9:00 CET. The webinar will include a Q&A session with CEO, Patrik Dahlen and Chairman, Carl Borrebaeck. Immunovia previously announced the CEO transition on August 26[th], 2020 (link to press release ). Patrik

Africa Oil Announces Second Significant Discovery on Block 11B/12B Offshore South Africa

VANCOUVER, October 28, 2020 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“AOI”, “Africa Oil” or “the Company”) is pleased to announce a significant gas condensate discovery on the Luiperd prospect located on Block 11B/12B offshore South Africa. This discovery follows the adjacent play-opening Brulpadda discovery in 2019, which proved a significant new petroleum province in the region. The Company holds an indirect interest in the project as a result of its equity interests in Africa Energy (31.3%) and Impact Oil & Gas Limited (31.1%). Garrett Soden, Africa Energy’s

Africa Energy Announces Second Significant Discovery Offshore South Africa

VANCOUVER, BC, October 28, 2020 /CNW/ – Africa Energy Corp. (TSX Venture: AFE, Nasdaq First North Growth Market: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, is pleased to announce a significant gas condensate discovery on the Luiperd prospect located on Block 11B/12B offshore South Africa. This discovery follows the adjacent play-opening Brulpadda discovery in 2019, which proved a significant new petroleum province in the region. Garrett Soden, Africa Energy’s President and CEO, commented, “We are thrilled to

Pekka Vauramo to continue as President and CEO of Metso Outotec until the end of 2023

Metso Outotec Corporation’s stock exchange release on October 28, 2020, at 09:10 a.m. EETPekka Vauramo will continue as the President and CEO of Metso Outotec until the end of 2023. “This is a unique opportunity to lead the integration of the two great companies into Metso Outotec and to develop Metso Outotec to become an industry leader. We are in the beginning of our integration journey and Metso Outotec has a lot of potential to increase the effectiveness of its operations and to serve its customers even better and in a more sustainable way,” says Pekka Vauramo.   “I´m pleased that

Finnair’s financial calendar and AGM in 2021

Finnair Plc          Stock Exchange Release           28 October 2020 at 9.05 EET A bulletin on Finnair Plc’s financial statements for 2020 will be published on Thursday 18 February 2021 at 09:00 a.m. EET. The financial statements 2020 will be published later the same day. The Annual General Meeting will be held on Wednesday 17 March 2021 at 3:00 p.m. EET in Helsinki. An official invitation to the meeting will be published later. The full financial calendar 2021 is as follows: · Financial Statements Bulletin for 2020 on Thursday 18 February 2021 · Interim Report for January–

Metso Outotec publishes its new strategy and financial targets

Metso Outotec Corporation’s stock exchange release on October 28, 2020, at 09:05 a.m. EETMetso Outotec, created through the combination of Metso Minerals and Outotec on June 30, 2020, has published its new strategy focusing on growth and improving profitability. The company aims to become a top-tier supplier of products, technologies and services in the aggregates and minerals industries and a top financial performer. Metso Outotec’s defined purpose is: “enabling sustainable modern life.”    Metso Outotec’s strong foundation for implementing its strategy and achieving its goals is

Ports Group chooses 700 square meters on Kungsgatan in Gothenburg

Ports Group, which is a market-leading company in brand security, has signed a lease with Wallenstam and is moving its headquarters from Mölnlycke to central Gothenburg. In January next year, it is moving into new premises of just over 700 square meters in order to increase its presence and accessibility in the middle of the city.“We are really looking forward to our move to new, modern premises in central Gothenburg. As a company, we protect brands – legally, digitally and technically and thereby create brand security in all areas of our customers’ brands. An attractive address as well as

Enhertu granted Priority Review in the US for the treatment of HER2-positive metastatic gastric cancer

28 October 2020 07:00 GMT Enhertu granted Priority Review in the US for thetreatment of HER2-positive metastatic gastric cancer Only HER2-directed medicine to demonstrate significant improvement in overall survival compared to chemotherapy for previously treated patients in this setting AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)'s Enhertu (trastuzumab deruxtecan) has received acceptance for its supplemental Biologics License Application (sBLA) and has also been granted Priority Review in the US for the treatment of patients with HER2-positive metastatic

Invitation to presentation of Balco’s third quarter report 2020

Växjö, 28 October 2020Balco’s interim report for the third quarter 2020 will be published at 07:30 CET on November 12, 2020. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Kenneth Lundahl and CFO Michael Grindborn will present the results for the third quarter 2020. A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Balco’s financial website, www.balcogroup.se or via the following link: https://tv.

Adapteo’s release date for the interim report January to September 2020 has been changed and is brought forward to 2 November

Adapteo Plc Press release 28 October 2020 at 8:00 a.m. CET Adapteo, a leading Northern European company for adaptable buildings, will publish its Business Review for January – September 2020 on Monday 2 November at approximately 07.30 CET. A conference call with a presentation for investors, analysts and media will be held at 09.00 CET the same day. The presentation will be held via teleconference and webcast by President & CEO Philip Isell Lind af Hageby and CFO Erik Skånsberg. The session will start with a presentation, followed by a question-and-answer session and will be held in

Forxiga cardiovascular outcomes benefit approved in China

28 October 2020 07:00 GMT Forxiga cardiovascular outcomes benefit approved in China Update to approval includes DECLARE-TIMI 58 Phase III trial that reduced the riskof composite of hospitalisation for heart failure or cardiovascular death in type-2 diabetes   China's National Medical Products Administration (NMPA) has updated the label for AstraZeneca's Forxiga (dapagliflozin) to include data from the DECLARE-TIMI 58 Phase III trial. DECLARE-TIMI 58 

UNION therapeutics appoints Dr. Kim Kjoeller as Chief Executive Officer and further strengthens leadership by appointing Dr. Günter Ditzinger as Chief Technology Officer

·UNION strengthens leadership following expansion of clinical pipeline from one to five later stage clinical candidates during 2020 · Dr. Kim Domela Kjoeller, Executive Vice President Global Research & Development at LEO Pharma A/S, has been appointed as new Chief Executive Officer with effect from January 1, 2021 · Dr. Günter Ditzinger, who holds 30 years of experience from Sanofi, Novartis and most recently as the Chief Technology Officer of Swiss-based Basilea Pharmaceutica, has been appointed as Chief Technology Officer  Hellerup, Denmark, October 28, 2020 – UNION

Interim Report July–September 2020: Record deliveries offset by a weaker market

LKAB has delivered a strong quarter with deliveries at a record high of 7.6 Mt. However, the effect on operating profit is offset by a lower dollar exchange rate, lower prices for highly upgraded iron ore products and increased costs.Net sales for the third quarter amounted to MSEK 9,333 (7,751), an increase of 20 percent compared with the same period last year. Operating profit decreased to MSEK 2,955 (3,128). The effect of high delivery volumes is offset by a lower dollar exchange rate, as well as lower prices for highly upgraded iron ore products and increased costs. The increased costs

There are no items matching the current filter
There are no more items matching the current filter
Back to top